PatientsVille.com Logo

PatientsVille

Pantoloc Side Effects

Common Pantoloc Side Effects


The most commonly reported Pantoloc side effects (click to view or check a box to report):

Diarrhoea (5)
Pyrexia (4)
Fatigue (4)
Nausea (3)
Pain In Extremity (3)
Hypomagnesaemia (3)
Pruritus (3)
Hypokalaemia (3)
Alanine Aminotransferase Increased (3)
Abdominal Pain (3)
Constipation (3)
Paraesthesia (2)
Off Label Use (2)
Hypertension (2)
Renal Failure (2)
Chills (2)
Oedema (2)
Aspartate Aminotransferase Increased (2)
Cutaneous Lupus Erythematosus (2)
Herpes Zoster (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Pantoloc Side Effects Reported to FDA

The following Pantoloc reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Pantoloc on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
White Blood Cell Count Increased, C-reactive Protein Increased, Pyrexia, Chills
This is a report of a 74-year-old female patient (weight: NA) from AT, suffering from the following symptoms/conditions: gastrooesophageal reflux disease, who was treated with Pantoloc (dosage: 40 Mg, Unk, start time: Feb 13, 2014), combined with:
  • Thyrex
  • Lisinopril
  • Salofalk (250 Mg, 3x/day)
and developed a serious reaction and side effect(s). The consumer presented with:
  • White Blood Cell Count Increased
  • C-reactive Protein Increased
  • Pyrexia
  • Chills
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Pantoloc treatment in female patients, resulting in white blood cell count increased side effect. The patient was hospitalized.

Visual Impairment
This report suggests a potential Pantoloc Visual Impairment side effect(s) that can have serious consequences. A 61-year-old male patient (weight: NA) from CN was diagnosed with the following symptoms/conditions: abdominal pain upper,gastric mucosal lesion and used Pantoloc (dosage: 40 Mg, 2x/day, Gtt) starting Oct 12, 2011. Soon after starting Pantoloc the patient began experiencing various side effects, including:
  • Visual Impairment
Drugs used concurrently: NA. Although Pantoloc demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as visual impairment, may still occur.

Granulocyte Count Decreased, Off Label Use
This Granulocyte Count Decreased, Off Label Use problem was reported by a health professional from CN. A 30-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: gastrointestinal haemorrhage. On NS this consumer started treatment with Pantoloc (dosage: 40 Mg, Daily). The following drugs were being taken at the same time: NA. When commencing Pantoloc, the patient experienced the following unwanted symptoms/side effects:
  • Granulocyte Count Decreased
  • Off Label Use
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as granulocyte count decreased, may become evident only after a product is in use by the general population.

Blood Pressure Decreased, Anaphylactic Shock, Abdominal Pain, Irritability
This is a report of a 45-year-old male patient (weight: NA) from CN. The patient developed the following symptoms/conditions: ulcer and was treated with Pantoloc (dosage: 80 Mg, 1x/day) starting Aug 20, 2007. Concurrently used drugs:
  • Sodium Chloride (100 Ml 0.9%)
Soon after that, the consumer experienced the following side effects:
  • Blood Pressure Decreased
  • Anaphylactic Shock
  • Abdominal Pain
  • Irritability
The patient was hospitalized. This opens a possibility that Pantoloc treatment could cause the above reactions, including blood pressure decreased, and some male subjects may be more susceptible.


Visual Impairment
A 45-year-old male patient (weight: NA) from CN with the following symptoms/conditions: NA started Pantoloc treatment (dosage: 40 Mg, 2x/day (gtt)) on Dec 24, 2008. Soon after starting Pantoloc treatment, the subject experienced various side effects, including:
  • Visual Impairment
Concurrently used drugs: NA. This finding indicates that some male patients could be more vulnerable to Pantoloc.

Dysgeusia
A 65-year-old female patient from AT (weight: NA) experienced symptoms, such as: NA and was treated with Pantoloc(dosage: 20 Mg, 1x/day). The treatment was initiated on Mar 18, 2013. After that a consumer reported the following side effect(s):
  • Dysgeusia
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Pantoloc efficacy: NA.

Clostridium Test Positive
In this report, Pantoloc was administered for the following condition: NA.A 56-year-old male consumer from CA (weight: NA) started Pantoloc treatment (dosage: 40 Mg, 1x/day) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Clostridium Test Positive
A possible interaction with other drugs could have contributed to this reaction: NA.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Pantoloc treatment could be related to the listed above side effect(s).

Eye Inflammation, Burning Sensation, Paraesthesia, Dry Skin, Fatigue, Swelling Face, Pruritus, Headache
This is a report of the following Pantoloc side effect(s):
  • Eye Inflammation
  • Burning Sensation
  • Paraesthesia
  • Dry Skin
  • Fatigue
  • Swelling Face
  • Pruritus
  • Headache
A 66-year-old female patient from SE (weight: NA) presented with the following condition: gastritis and received a treatment with Pantoloc (dosage: 20 Mg, Daily) starting: NS.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Pantoloc treatment could be associated with the listed above side effect(s).

Blood Alkaline Phosphatase Increased, Chromaturia, Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
This Pantoloc report was submitted by a 55-year-old female consumer from CA (weight: NA). The patient was diagnosed with: gastritis and Pantoloc was administered (dosage: 40 Mg, 2x/day) starting: Apr 27, 2012. The consumer developed a set of symptoms:
  • Blood Alkaline Phosphatase Increased
  • Chromaturia
  • Abdominal Pain
  • Alanine Aminotransferase Increased
  • Aspartate Aminotransferase Increased
Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Pantoloc treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Anal Stenosis
This is a report of a possible correlation between Pantoloc use and the following symptoms/side effect(s):
  • Anal Stenosis
which could contribute to an assessment of Pantoloc risk profile.A 49-year-old male consumer from COUNTRY NOT SPECIFIED (weight: NA) was suffering from gastrooesophageal reflux disease,iron deficiency,osteoporosis and was treated with Pantoloc (dosage: NA) starting 200402.Other concurrent medications:
  • Ferretab
  • Fosamax
  • Kombi Kalz
  • Humira (Baseline)
  • Humira (Week 2)
  • Humira
  • Azathioprine
  • Azathioprine
The patient was hospitalized.

Gastrointestinal Haemorrhage, Hiatus Hernia, Mallory-weiss Syndrome, Tablet Physical Issue, Dysuria, Off Label Use
A 83-year-old female patient from AT (weight: NA) presented with the following symptoms: nausea,anaemia and after a treatment with Pantoloc (dosage: 40 Mg, 2x/day) experienced the following side effect(s):
  • Gastrointestinal Haemorrhage
  • Hiatus Hernia
  • Mallory-weiss Syndrome
  • Tablet Physical Issue
  • Dysuria
  • Off Label Use
The treatment was started on Jan 13, 2013. Pantoloc was used in combination with the following drugs: NA.This report could alert potential Pantoloc consumers.

Erythema, Face Oedema
In this report, a 52-year-old female patient from DE (weight: NA) was affected by a possible Pantoloc side effect.The patient was diagnosed with NA. After a treatment with Pantoloc (dosage: 20 Mg, Qd, start date: Jan 06, 2013), the patient experienced the following side effect(s):
  • Erythema
  • Face Oedema
The following simultaneously used drugs could have led to this reaction:
  • Drospirenone (Unk)
  • Ethinly Estradiol (Unk)
  • Yasmin (Unk)
  • Zirtec (Unk)
The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Pantoloc treatment.

Hyperuricaemia
This is a report of a 55-year-old female patient from AT (weight: NA), who used Pantoloc (dosage: 40 Mg, Daily) for a treatment of gastrointestinal disorder,kidney transplant. After starting a treatment on May 11, 2010, the patient experienced the following side effect(s):
  • Hyperuricaemia
The following drugs could possibly have interacted with the Pantoloc treatment
  • Myfortic (1440 Mg, Daily)
  • Myfortic (1080 Mg, Daily)
  • Tacrolimus (4 Mg, Daily)
  • Paspertin (Unk)
  • Aprednislon (10 / 5 Mg, Daily, Alternating)
  • Aprednislon (5 Mg, Daily)
  • Concor (Unk)
  • Neurobion Forte (Unk)
Taken together, these observations suggest that a Pantoloc treatment could be related to side effect(s), such as Hyperuricaemia.

Cerebrovascular Accident, Hypertension, Anaemia, Haemoglobin Decreased, Fatigue, Herpes Zoster, Dyspepsia, Constipation
This cerebrovascular accident side effect was reported by a consumer or non-health professional from CA. A 81-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Pantoloc (dosage: Unk), which was started on 201210. Concurrently used drugs: NA. When starting to take Pantoloc the consumer reported the following symptoms:
  • Cerebrovascular Accident
  • Hypertension
  • Anaemia
  • Haemoglobin Decreased
  • Fatigue
  • Herpes Zoster
  • Dyspepsia
  • Constipation
The patient was hospitalized. These side effects may potentially be related to Pantoloc.

Septic Shock, Multi-organ Failure, Agranulocytosis, Thrombocytopenia
This is a Pantoloc side effect report of a 72-year-old male patient (weight:NA) from AT, suffering from the following symptoms/conditions: ulcer,pain,pancreatitis, who was treated with Pantoloc (dosage:NA, start time: Jul 21, 2012), combined with:
  • Novalgin
  • Optinem
  • Dipidolor
  • Lovenox
  • Actrapid
  • Ratiograstim
  • Diflucan
  • Relistor
, and developed a serious reaction and a septic shock side effect. The patient presented with:
  • Septic Shock
  • Multi-organ Failure
  • Agranulocytosis
  • Thrombocytopenia
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Pantoloc treatment in male patients suffering from ulcer,pain,pancreatitis, resulting in septic shock.

Hypomagnesaemia, Atrial Fibrillation, Hypokalaemia
This report suggests a potential Pantoloc hypomagnesaemia side effect(s) that can have serious consequences. A 72-year-old female patient from CA (weight:NA) was diagnosed with the following health condition(s): NA and used Pantoloc (dosage: Unk) starting NS. Soon after starting Pantoloc the patient began experiencing various side effects, including:
  • Hypomagnesaemia
  • Atrial Fibrillation
  • Hypokalaemia
Drugs used concurrently:
  • Adalat (Unk)
  • Lantus (Unk)
  • Metoprolol (Unk)
  • Synthroid
The patient was hospitalized. Although Pantoloc demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as hypomagnesaemia, may still occur.

Mouth Haemorrhage
This mouth haemorrhage problem was reported by a physician from KOREA, REPUBLIC OF. A male patient (weight: NA) was diagnosed with the following medical condition(s): NA.On Jun 17, 2011 a consumer started treatment with Pantoloc /01263202/ (dosage: NA). The following drugs/medications were being taken at the same time:
  • Gemcitabine Hydrochloride (2125 Mg, Other)
  • Almagel
  • Necitumumab (11f8) (ly3012211) (800 Mg, Unk)
  • Cisplatin (127 Mg, Other)
  • Megace
When commencing Pantoloc /01263202/, the patient experienced the following unwanted symptoms /side effects:
  • Mouth Haemorrhage
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as mouth haemorrhage, may become evident only after a product is in use by the general population.

Pyrexia, Renal Failure, Diabetic Nephropathy, Oedema, Diabetes Mellitus, Fatigue, Eczema, Hypertension
This is a Pantoloc /01263204/ side effect report of a 71-year-old female patient (weight: NA) from AUSTRIA. The patient developed the following symptoms/conditions: NA and was treated with Pantoloc /01263204/ (dosage: 40 Mg, Unk) starting Oct 18, 2011. Concurrently used drugs:
  • Candesartan Cilexetil/hydrochlorothiazide (16 Mg, Unk)
  • Bisoprolol Fumarate (2.5 Mg, Unk)
  • Aspirin (100 Mg, Unk)
  • Ebastine
  • Halcion
  • Simvastatin (40 Mg, Unk)
  • Adamon /00599202/ (150 Mg, Unk)
  • Urbason /00049601/ (60 Mg, Qd)
Soon after that, the consumer experienced the following of symptoms:
  • Pyrexia
  • Renal Failure
  • Diabetic Nephropathy
  • Oedema
  • Diabetes Mellitus
  • Fatigue
  • Eczema
  • Hypertension
The patient was hospitalized. This opens a possibility that Pantoloc /01263204/ could cause pyrexia and that some female patients may be more susceptible.

Depressive Symptom, Suicide Attempt, Anxiety, Incorrect Dose Administered, Renal Impairment
A 68-year-old male patient (weight: NA) from GERMANY with the following symptoms: NA started Pantoloc (pantoprazole) (pantoprazole) treatment (dosage: NA) on Jan 30, 2011. Soon after starting Pantoloc (pantoprazole) (pantoprazole) treatment, the consumer experienced several side effects, including:
  • Depressive Symptom
  • Suicide Attempt
  • Anxiety
  • Incorrect Dose Administered
  • Renal Impairment
. Concurrently used drugs:
  • Roflumilast (roflumilast) (tablets) (500 Mcg (500 Mcg,1 In 1 D))
  • Ibuprofen ((6 Gm,once))
  • Alendronate (alendronate Sodium) (alendronate Sodium)
  • Unikalk Senior / Silver (calcium, Cholecalciferol) (calcium, Cholecalc
  • Alfuzosin (alfuzosin) (alfuzosin)
  • Zopiclone (zopiclone) ((75 Mg,once))
  • Seretide (salmeterol, Fluticasone) (salmeterol, Fluticasone)
  • Furix (furosemide) (furosemide)
The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Pantoloc (pantoprazole) (pantoprazole) side effects, such as depressive symptom.

Palpitations, Headache, Throat Irritation, Nightmare, Dyspepsia, Constipation, Hyperhidrosis
This palpitations side effect was reported by a consumer or non-health professional from CANADA. A 70-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Pantoloc ^nycomed^ (dosage: 40 Mg, 1x/day In The Morning), which was started on Jun 01, 2006. Concurrently used drugs:
  • Lipitor (40 Mg, 1x/day At Bedtime)
  • Lipitor (5 Mg, 1x/day At Bedtime)
  • Lipitor (20 Mg, 1x/day At Bedtime)
  • Lovaza (1 Tablet, 2x/day)
  • Sitagliptin Phosphate (100 Mg, 1x/day)
  • Asaphen (80 Mg, 1x/day)
  • Synthroid (0.05 Mg, Unk)
  • Lipitor (10 Mg, 1x/day At Bedtime)
.When starting to take Pantoloc ^nycomed^ the consumer reported symptoms, such as:
  • Palpitations
  • Headache
  • Throat Irritation
  • Nightmare
  • Dyspepsia
  • Constipation
  • Hyperhidrosis
These side effects may potentially be related to Pantoloc ^nycomed^.

Balance Disorder, Blood Sodium Increased, Vomiting, Gait Disturbance, Constipation, Neoplasm Progression
This is a report of a male patient (weight: NA) from CANADA, suffering from the following symptoms/conditions: NA, who was treated with Pantoloc (dosage: NA, start time: Mar 18, 2011), combined with:
  • Acetaminophen (Taken Once)
  • Methylprednisolone (Taken Once)
  • Bevacizumab (Form: Infusion)
  • Decadron (Dose: 4 Qid)
  • Zofran (6-8 Mg In Am)
  • Bevacizumab
  • Frisium
  • Diphenhydramine Hydrochloride (Taken Once)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Balance Disorder
  • Blood Sodium Increased
  • Vomiting
  • Gait Disturbance
  • Constipation
  • Neoplasm Progression
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Pantoloc treatment in male patients, resulting in balance disorder side effect. The patient was hospitalized.

Intestinal Stenosis
This report suggests a potential Pantoloc Intestinal Stenosis side effect(s) that can have serious consequences. A male patient (weight: NA) from CANADA was diagnosed with the following symptoms/conditions: NA and used Pantoloc (dosage: NA) starting Jan 01, 2011. Soon after starting Pantoloc the patient began experiencing various side effects, including:
  • Intestinal Stenosis
Drugs used concurrently:
  • Remicade
  • Remicade
  • Ferrous Sulfate Tab
  • Imuran
Although Pantoloc demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as intestinal stenosis, may still occur.

Back Pain, Spinal Compression Fracture
This Back Pain, Spinal Compression Fracture problem was reported by a consumer or non-health professional from CANADA. A 72-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Feb 09, 2011 this consumer started treatment with Pantoloc /01263202/ (dosage: NA). The following drugs were being taken at the same time:
  • Forteo (20 Ug, Qd)
  • Insulin
  • Lyrica
  • Crestor
  • Norvasc
  • Lantus
  • Senokot
  • Tylenol /sch/ (Unk, Prn)
When commencing Pantoloc /01263202/, the patient experienced the following unwanted symptoms/side effects:
  • Back Pain
  • Spinal Compression Fracture
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as back pain, may become evident only after a product is in use by the general population.

Eyelid Ptosis, Oedema, Hypoaesthesia Facial
This is a report of a 56-year-old female patient (weight: NA) from CANADA. The patient developed the following symptoms/conditions: rheumatoid arthritis and was treated with Pantoloc (dosage: NA) starting NS. Concurrently used drugs:
  • Methotrexate
  • Folic Acid (6 Days/week)
  • Remicade
  • Voltaren
Soon after that, the consumer experienced the following side effects:
  • Eyelid Ptosis
  • Oedema
  • Hypoaesthesia Facial
The patient was hospitalized. This opens a possibility that Pantoloc treatment could cause the above reactions, including eyelid ptosis, and some female subjects may be more susceptible.

Thyroid Cancer
A female patient (weight: NA) from AUSTRIA with the following symptoms/conditions: NA started Pantoloc treatment (dosage: NA) on Oct 10, 2009. Soon after starting Pantoloc treatment, the subject experienced various side effects, including:
  • Thyroid Cancer
Concurrently used drugs:
  • Calcium D3
  • Humira
  • Ferrous Sulfate Tab
  • Quantalan
  • Entocort Ec
  • Aprednislon
The patient was hospitalized and became disabled. This finding indicates that some female patients could be more vulnerable to Pantoloc.

1 of 3 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Pantoloc Side Effects

    Did You Have a Pantoloc Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Pantoloc for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Pantoloc Safety Alerts, Active Ingredients, Usage Information

    More About Pantoloc

    Side Effects reported to FDA: 62

    Pantoloc safety alerts: No

    Reported deaths: 6

    Reported hospitalizations: 19

    Latest Pantoloc clinical trials